7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Chronic Disease D002908 7 associated lipids
Cleidocranial Dysplasia D002973 1 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Crohn Disease D003424 12 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dengue D003715 2 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Kats A et al. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. 2016 J. Cell. Mol. Med. pmid:26987561
Moran CS et al. Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. 2016 Arterioscler. Thromb. Vasc. Biol. pmid:26966276
Zhou QL et al. Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. 2016 Mol Med Rep pmid:27357904
Cong Q et al. p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. 2016 Stem Cell Reports pmid:26947973
Wang C et al. Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. 2016 Med. Sci. Monit. pmid:26939934
Lin J et al. Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. 2016 Nat Commun pmid:26923114
D'Abramo A et al. Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. 2016 PLoS ONE pmid:26913505
Lu J et al. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. 2016 Exp. Biol. Med. (Maywood) pmid:26908571
Stuss M et al. Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. 2016 Endokrynol Pol pmid:26884284
Gluba-Brzózka A et al. Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. 2016 Lipids Health Dis pmid:26843213
Gautam J et al. An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. 2016 J. Pharm. Pharmacol. pmid:27265669
Bumdelger B et al. Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms. 2016 PLoS ONE pmid:26783750
Owen S et al. Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. 2016 Int. J. Oncol. pmid:26781475
Maser RE et al. Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. 2016 J. Diabetes Complicat. pmid:26775555
Gottesman GS et al. Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. 2016 Am. J. Med. Genet. A pmid:26762549
Theodoro LH et al. Effect of low-level laser therapy as an adjuvant in the treatment of periodontitis induced in rats subjected to 5-fluorouracil chemotherapy. 2016 J. Periodont. Res. pmid:26750739
Alam I et al. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. 2016 Endocrinology pmid:26584014
Mitchell JA et al. Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density. 2016 J. Bone Miner. Res. pmid:26572781
Melchiorre D et al. Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A. 2016 Haematologica pmid:26494839
Wang HL et al. Protein biomarkers and microbial profiles in peri-implantitis. 2016 Clin Oral Implants Res pmid:26424287
Liu G et al. Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. 2016 Cell Tissue Res. pmid:26004143
Bergamini A et al. Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. 2016 Int J Med Sci pmid:28090190
Toffoli B et al. Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. 2016 Mediators Inflamm. pmid:28070143
Chen H et al. [Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. 2016 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:28070039
Kainuma S et al. Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts. 2016 Mol Med Rep pmid:26935864
Shimazaki E et al. TGF-β and Physiological Root Resorption of Deciduous Teeth. 2016 Int J Mol Sci pmid:28035998
Bolamperti S et al. Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture. 2016 Biomed Res Int pmid:27999816
Li Y et al. Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province. 2016 J. Genet. pmid:27994198
Gómez-Vaquero C et al. Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. 2016 PLoS ONE pmid:27911913
Zhang L et al. Role of Osteoprotegerin (OPG) in Bone Marrow Adipogenesis. 2016 Cell. Physiol. Biochem. pmid:27898403
Biscetti F et al. RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population. 2016 Eur Rev Med Pharmacol Sci pmid:27874938
Liu FQ et al. Effects of Salt Loading on Plasma Osteoprotegerin Levels and Protective Role of Potassium Supplement in Normotensive Subjects. 2016 Circ. J. pmid:27867157
Kim CS et al. Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. 2016 PLoS ONE pmid:27855207
Li XJ et al. Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. 2016 Int. J. Mol. Med. pmid:27840967
Piemontese M et al. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:27460899
Zhao JJ et al. MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. 2016 PLoS ONE pmid:27459539
Ugay L et al. Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. 2016 Chin. Med. J. pmid:27411457
Pellegrini GG et al. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. 2016 Nutrients pmid:27409635
Nagy EE et al. High circulating osteoprotegerin levels are associated with non-zero blood groups. 2016 BMC Cardiovasc Disord pmid:27387019
Zhang YY et al. Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. 2016 Chin J Dent Res pmid:27379348
Songia P et al. Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. 2016 J. Mol. Cell. Cardiol. pmid:27338002
Li Y et al. OPG and RANKL polymorphisms are associated with alcohol-induced osteonecrosis of the femoral head in the north area of China population in men. 2016 Medicine (Baltimore) pmid:27336899
Dolan EB et al. Thermally induced osteocyte damage initiates pro-osteoclastogenic gene expression in vivo. 2016 J R Soc Interface pmid:27335224
Kassem A et al. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. 2016 PLoS ONE pmid:27311019
Wang JH et al. Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesions. 2016 Medicine (Baltimore) pmid:27310953
Yamada C et al. TGF-β in jaw tumor fluids induces RANKL expression in stromal fibroblasts. 2016 Int. J. Oncol. pmid:27279422
He M et al. Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis. 2016 Mol Med Rep pmid:27277157
Ye C et al. [Effect of MT01/PEN complexes on the expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in human osteoblast-like cell line MG63]. 2016 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:27266195
Bernardi S et al. Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. 2016 Biomed Res Int pmid:27200369
Wei CC et al. Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis. 2016 Mediators Inflamm. pmid:27199510

Table of Content